FDA Clearance Tracker · P140012-S012
ReShape Integrated Dual Balloon System
Last checked: Nov 20, 2026Latest source record: May 30, 2018 (this decision)Source: openFDAMethods & limitations
Decided
May 30, 2018
Approved
Time to decision
93 days
Received Feb 26, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140012-S012
- Device name
- ReShape Integrated Dual Balloon System
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marlboro, MA
- Received
- Feb 26, 2018
- Decided
- May 30, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P140012
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol of the post-approval study protocol.
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.